                         SEQUENCE LISTING

<110>  ETABLISSEMENT FRANCAIS DU SANG
       UNIVERSITE DE MONTPELLIER
       INSERM (INSTITUT NATIONAL DE LA SANT ET DE LA RECHERCHE 
       MDICALE)
       HORIBA ABX SAS
 
<120>  DETECTION OF INFECTIOUS AGENT BASED ON RECOMBINASE POLYMERASE 
       AMPLIFICATION COMBINED WITH A MAGNETIC FIELD-ENHANCED 
       AGGLUTINATION

<130>  BET 21P0786

<160>  8     

<170>  PatentIn version 3.5

<210>  1
<211>  34
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  DENV forward primer

<400>  1
aacagcatat tgacgctggg agagaccaga gatc                                   34


<210>  2
<211>  36
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  DENV reverse primer

<400>  2
attcaacagc accattccat tttctggcgt tctgtg                                 36


<210>  3
<211>  34
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  SARS-COV2 forward primer

<400>  3
cttcaaccta ggacttttct attaaaatat aatg                                   34


<210>  4
<211>  33
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  SARS-COV2 reverse primer

<400>  4
gttggttgga ctctaaagtt agaagtttga tag                                    33


<210>  5
<211>  15
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  DENV probe

<400>  5
tggaatgatg ctgta                                                        15


<210>  6
<211>  15
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  SARS-COV2 probe

<400>  6
agtctacagc atctg                                                        15


<210>  7
<211>  24
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  SARS-COV2 probe

<400>  7
cacagtctac agcatctgta atgg                                              24


<210>  8
<211>  15
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Zirka virus forward primer

<400>  8
agcaagggga atttg                                                        15


